210 related articles for article (PubMed ID: 14701702)
1. JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells.
Davison K; Mann KK; Waxman S; Miller WH
Blood; 2004 May; 103(9):3496-502. PubMed ID: 14701702
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P
J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
[TBL] [Abstract][Full Text] [Related]
3. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
Chen D; Chan R; Waxman S; Jing Y
Cancer Res; 2006 Dec; 66(23):11416-23. PubMed ID: 17145888
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
Kitamura K; Minami Y; Yamamoto K; Akao Y; Kiyoi H; Saito H; Naoe T
Leukemia; 2000 Oct; 14(10):1743-50. PubMed ID: 11021749
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase.
Shim MJ; Kim HJ; Yang SJ; Lee IS; Choi HI; Kim T
J Biochem Mol Biol; 2002 Jul; 35(4):377-83. PubMed ID: 12296996
[TBL] [Abstract][Full Text] [Related]
6. Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1.
Kajiguchi T; Yamamoto K; Hossain K; Akhand AA; Nakashima I; Naoe T; Saito H; Emi N
Leukemia; 2003 Nov; 17(11):2189-95. PubMed ID: 12931215
[TBL] [Abstract][Full Text] [Related]
7. 12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione.
Fernández C; Ramos AM; Sancho P; Amrán D; de Blas E; Aller P
J Biol Chem; 2004 Jan; 279(5):3877-84. PubMed ID: 14610070
[TBL] [Abstract][Full Text] [Related]
8. PRAM-1 potentiates arsenic trioxide-induced JNK activation.
Denis FM; Benecke A; Di Gioia Y; Touw IP; Cayre YE; Lutz PG
J Biol Chem; 2005 Mar; 280(10):9043-8. PubMed ID: 15637062
[TBL] [Abstract][Full Text] [Related]
9. Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines.
Davison K; Côté S; Mader S; Miller WH
Leukemia; 2003 May; 17(5):931-40. PubMed ID: 12750708
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
[TBL] [Abstract][Full Text] [Related]
11. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
Kajiguchi T; Yamamoto K; Iida S; Ueda R; Emi N; Naoe T
Cancer Sci; 2006 Jun; 97(6):540-5. PubMed ID: 16734734
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
[TBL] [Abstract][Full Text] [Related]
14. A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
Diaz Z; Mann KK; Marcoux S; Kourelis M; Colombo M; Komarnitsky PB; Miller WH
Leukemia; 2008 Oct; 22(10):1853-63. PubMed ID: 18633430
[TBL] [Abstract][Full Text] [Related]
15. Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.
Dolniak B; Katsoulidis E; Carayol N; Altman JK; Redig AJ; Tallman MS; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Platanias LC
J Biol Chem; 2008 May; 283(18):12034-42. PubMed ID: 18299328
[TBL] [Abstract][Full Text] [Related]
16. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway.
Jing Y; Dai J; Chalmers-Redman RM; Tatton WG; Waxman S
Blood; 1999 Sep; 94(6):2102-11. PubMed ID: 10477740
[TBL] [Abstract][Full Text] [Related]
18. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4.
Bernardini S; Nuccetelli M; Noguera NI; Bellincampi L; Lunghi P; Bonati A; Mann K; Miller WH; Federici G; Lo Coco F
Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740
[TBL] [Abstract][Full Text] [Related]
19. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
Giafis N; Katsoulidis E; Sassano A; Tallman MS; Higgins LS; Nebreda AR; Davis RJ; Platanias LC
Cancer Res; 2006 Jul; 66(13):6763-71. PubMed ID: 16818652
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis.
Hayakawa F; Privalsky ML
Cancer Cell; 2004 Apr; 5(4):389-401. PubMed ID: 15093545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
